Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration

By MarketWatch | Nov 20, 2024 at 07:02 PM EST

Kura Oncology's stock declined 14% in after-hours trading due to a collaboration deal with Kyowa Kirin for its leukemia treatment. The agreement includes significant upfront and milestone payments, with both companies sharing drug development and profits.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.